Results 11 to 20 of about 98,309 (302)
Important Diagnostic Clues for Diagnosing Splenic Marginal Zone Lymphoma in Absence of Splenic Histology [PDF]
Journal of Clinical and Diagnostic Research, 2017 Splenic Marginal Zone Lymphoma (SMZL) is a rare B-cell neoplasm comprising less than 2% of non-Hodgkin lymphomas. We hereby report a case of SMZL in a 66-year-old female who presented with fever and massive splenomegaly.
Anisha Mohanpuria +4 more
doaj +1 more source
Gynecology and Minimally Invasive Therapy, 2020 Ovarian diffuse large B-cell lymphoma (DLBCL) is rare. DLBCL is a complex type of lymphoma. The ovarian DLBCL usually harbor a favorable prognosis. We report a case of ovarian DLBCL that presented as an ovarian mass with lower abdominal pain and was ...
Pei- Chen Li +3 more
doaj +1 more source
, 2022 IntroductionThe anti-CD20 antibody rituximab (RTX) has substantially improved outcomes of patients with B-cell lymphomas, although more efficient therapies are needed for refractory or relapsing lymphomas.
Claudia Plasencia (14238803) +16 more
core +1 more source
On the markers for schizophrenia
Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева, 2021 Summary. The study of various markers indicating an imbalance in both the neurotransmitter and immune systems observed in patients with schizophrenia is currently of great scientific and practical interest.
A. N. Erichev +4 more
doaj +1 more source
, 2022 Supplementary Data from 89Zr-ImmunoPET Shows Therapeutic Efficacy of Anti-CD20-IFNα Fusion Protein in a Murine B-cell Lymphoma ...
John M. Timmerman (14931225) +7 more
core +1 more source
Mouse CD20 expression and function [PDF]
International Immunology, 2004 CD20 plays a role in human B cell proliferation and is an effective target for immunotherapy. In this study, mouse CD20 expression and biochemistry were assessed for the first time using a new panel of CD20-specific mAb, with CD20 function assessed using CD20-deficient (CD20(-/-)) mice.
Junji, Uchida +10 more
openaire +2 more sources
Binding mechanisms of therapeutic antibodies to human CD20 [PDF]
, 2020 International audienceMonoclonal antibodies (mAbs) targeting human antigen CD20 (cluster of differentiation 20) constitute important immunotherapies for the treatment of B cell malignancies and autoimmune diseases.
Reyes, Nicolas +4 more
core +1 more source
Antibodies, 2022 This study aimed to investigate PD-L1 and PD-1 expression in circulating CD20+ cells in diffuse larger B-cell lymphoma (DLBCL) and to evaluate the predictive and diagnostic performance of PD-L1 versus PD-1 expression in circulating CD20+ cells in DLBCL ...
Manal Mohamed Saber
doaj +1 more source
GAS5 Long Noncoding RNA Regulates CD20 Expression and Rituximab Response [PDF]
Advanced Pharmaceutical BulletinPurpose: Rituximab is the primary treatment for non-Hodgkin lymphoma (NHL), one of the most common cancers globally. One of the main challenges associated with rituximab therapy is the decline in its effectiveness over time.
Mahbubeh Rojhannezhad +3 more
doaj +1 more source
Monoclonal antibodies targeting CD20 [PDF]
mAbs, 2013 Letter to the Editor: We are commenting on the article by Klein et al. on the functional properties of several anti-CD20 monoclonal antibodies (mAbs) in the January/February 2013 issue of this journal.1 Rituximab, the first monoclonal antibody approved for cancer therapy, has truly revolutionized the treatment of a variety of CD20+ hematological ...
Chang, Chien-Hsing +2 more
openaire +2 more sources